Core Scientific (CORZ) legal officer sells 10,000 shares under 10b5-1 plan
Rhea-AI Filing Summary
Core Scientific, Inc. (CORZ) Chief Legal and Administrative Officer Todd M. Duchene reported selling a total of 10,000 shares of common stock on July 27, 2026, in three transactions reported as open-market or private sales.
The sales comprised 8,300 shares at $20.7469, 1,600 shares at $21.8925, and 100 shares at $22.4900 per share. The 8,300‑ and 1,600‑share trades were executed at weighted average prices within ranges of $20.47–$21.42 and $21.47–$22.44, respectively. All transactions were effected under a Rule 10b5-1 trading plan adopted on December 5, 2025.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 10,000 shares
Net Sell
3 txns
Insider
DUCHENE TODD M
Role
See remarks
Sold
10,000 shs ($209K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F2 | 8,300 | $20.7469 | $172K |
| Sale | Common Stock F1, F3 | 1,600 | $21.8925 | $35K |
| Sale | Common Stock F1 | 100 | $22.49 | $2K |
Holdings After Transaction:
Common Stock — 1,989,101 shares (Direct)
Footnotes (3)
- F1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025.
- F2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.47 to $21.42, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- F3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.47 to $22.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Key Figures
Total shares sold: 10,000 shares
First block sold: 8,300 shares at $20.7469 per share
Second block sold: 1,600 shares at $21.8925 per share
+4 more
7 metrics
Total shares sold
10,000 shares
Aggregate common stock sold by Todd M. Duchene on July 27, 2026
First block sold
8,300 shares at $20.7469 per share
Common stock sale reported as weighted average within $20.47–$21.42 range
Second block sold
1,600 shares at $21.8925 per share
Common stock sale reported as weighted average within $21.47–$22.44 range
Third block sold
100 shares at $22.4900 per share
Common stock sale on July 27, 2026 reported at a single per-share price
Rule 10b5-1 plan adoption date
December 5, 2025
Date Todd M. Duchene adopted the trading plan used for these transactions
First trade price range
$20.47–$21.42
Range of individual execution prices for the 8,300-share weighted-average sale
Second trade price range
$21.47–$22.44
Range of individual execution prices for the 1,600-share weighted-average sale
Key Terms
Rule 10b5-1 trading plan, weighted average price, open market or private transaction
3 terms
Rule 10b5-1 trading plan regulatory
"transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported is a weighted average price. These shares were sold in multiple transactions"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
open market or private transaction regulatory
"transaction code description states: Sale in open market or private transaction"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
Were the Core Scientific (CORZ) insider sales made under a Rule 10b5-1 plan?
Yes. The filing states that all reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by Todd M. Duchene on December 5, 2025, and the Rule 10b5-1 checkbox in the form is affirmed.
On what date did the insider transactions in Core Scientific (CORZ) occur?
All reported transactions took place on July 27, 2026. On that date, Todd M. Duchene executed three sales totaling 10,000 shares of Core Scientific common stock at the prices and ranges disclosed in the Form 4.
What do the price ranges in the Core Scientific (CORZ) Form 4 indicate?
The filing explains that some prices are weighted averages across multiple trades. For 8,300 shares, executions ranged from $20.47–$21.42, and for 1,600 shares from $21.47–$22.44, with detailed breakdowns available from the reporting person upon request.